MedPath

Fosinopril sodium

Fosinopril Sodium Tablets, USP, for oral use Rx only

Approved
Approval ID

3d521d4d-29f8-40d7-971b-0efb68dfbff2

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 27, 2023

Manufacturers
FDA

Bryant Ranch Prepack

DUNS: 171714327

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

fosinopirl sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71335-0726
Application NumberANDA205670
Product Classification
M
Marketing Category
C73584
G
Generic Name
fosinopirl sodium
Product Specifications
Route of AdministrationORAL
Effective DateOctober 1, 2017
FDA Product Classification

INGREDIENTS (6)

FOSINOPRIL SODIUMActive
Quantity: 10 mg in 1 1
Code: NW2RTH6T2N
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
POVIDONE K29/32Inactive
Code: 390RMW2PEQ
Classification: IACT
SODIUM STEARYL FUMARATEInactive
Code: 7CV7WJK4UI
Classification: IACT
CROSPOVIDONE (120 .MU.M)Inactive
Code: 68401960MK
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Fosinopril sodium - FDA Drug Approval Details